New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2014
04:55 EDTSIAL, SIAL, SIAL, MMS, MMS, MMS, MD, MD, MD, MASI, MASI, MASI, LPNT, LPNT, LPNT, STE, STE, STE, XRAY, XRAY, XRAY, MRK, MRK, MRK, JNJ, JNJ, JNJCitigroup to host a conference
Global Healthcare Conference is being held in New York on February 24-26.
News For SIAL;MMS;MD;MASI;LPNT;STE;XRAY;MRK;JNJ From The Last 14 Days
Check below for free stories on SIAL;MMS;MD;MASI;LPNT;STE;XRAY;MRK;JNJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
July 25, 2014
08:54 EDTJNJEMA issues positive opinion, recommends approval of Imbruvica
Subscribe for More Information
07:17 EDTJNJEMA recommends approval for Gilead, Janssen blood cancer drugs
Subscribe for More Information
07:06 EDTLPNTLifePoint Hospitals sees FY14 EPS $2.99-$3.19, consensus $2.71
Subscribe for More Information
07:03 EDTLPNTLifePoint reports Q2 EPS from cont. ops. 84c, may not compare to consensus 55c
Reports Q2 revenues from continuing operations $1.05B, consensus $1.01B.
July 24, 2014
09:16 EDTJNJOn The Fly: Pre-market Movers
Subscribe for More Information
08:39 EDTJNJOrganovo enters 3D bio-printed tissue agreement with J&J unit
Organovo (ONVO) announced that it has entered into an agreement with Janssen Research and Development, a pharmaceutical company of Johnson & Johnson (JNJ), to evaluate the use of 3D bio-printed tissue in a drug discovery setting, outside of the company’s work in 3D liver tissue for toxicity testing. Terms were not disclosed.
08:32 EDTMRKMerck initiates Phase 3 study of Letermovir
Subscribe for More Information
08:19 EDTJNJLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
07:15 EDTSIALSigma-Aldrich sees FY14 organic sales growth in low-single digit range
Sees organic sales growth in 2H14, with Research to be in low-to-mid single digits, Applied in mid-single digits and SAFC Commercial in mid-single digits. Sees FY14 adjusted operating income margin to improve by 50 basis points. Sees FY14 effective tax rate of 27%; Sees FY14 CapEx $130M; Sees FY14 free cash flow to exceed $475M.
07:13 EDTSIALSigma-Aldrich making 'good progress' on long-term initiatives
Subscribe for More Information
07:13 EDTSIALSigma-Aldrich raises FY14 adjusted EPS to $4.32-$4.40 from $4.30-$4.40
FY14 EPS consensus of $4.37.
07:12 EDTSIALSigma-Aldrich reports Q2 adjusted EPS $1.11, consensus $1.10
Reports Q2 revenue $701M, consensus $705.93M; Reports Q2 organic sales growth flat in Research 6% in Applied and 1% in SAFC Commercial
July 22, 2014
13:46 EDTLPNTCourt upholds Obamacare subsidies, NY Times says
Subscribe for More Information
12:16 EDTLPNTU.S. to appeal ruling on health care insurance subsidies, Politico says
Subscribe for More Information
July 21, 2014
18:40 EDTJNJOn The Fly: After Hours Movers
UP AFTER EARNINGS: Netflix (NFLX), up marginally after reporting Q2 results... Sanmina (SANM), up 13.2% after reporting third quarter results and fourth quarter guidance above analyst estimates... Chipotle (CMG), up 10.1%... Helix (HLX), up 5.2%... Canadian National (CNI), up 1.13%... CYS Investments (CYS), up 1.7%. ALSO HIGHER: Apache (APA), up 5% after Bloomberg says JANA discloses $1B position... Johnson & Johnson (JNJ), up 1% after announcing a $5B share repurchase program... TG Therapeutics (TGTX), up 4.3% after reporting second quarter results and preliminary clinical results from TG-1101 Phase I study... DOWN AFTER EARNINGS: Rambus (RMBS), down 3.6% after reporting second quarter results... Ultra Clean (UCTT), down 4% after reporting quarterly results. ALSO LOWER: Tallgrass Energy (TEP), down 5% after filing to sell 7M common units representing limited partners.
17:03 EDTJNJJohnson & Johnson announces $5B share repurchase program
Johnson & Johnson announced that its board has approved the repurchase of up to $5B of the company's common stock. The company had approximately 2.82B shares of common stock outstanding as of June 29.
17:01 EDTJNJJohnson & Johnson announces $5B share repurchase program
10:31 EDTSIALHigh option volume stocks:
High option volume stocks: EZPW LCI STLD SIAL FL OREX CROX NIHD EXTR BBT
07:21 EDTMRKGilead could be hurt by new HCV drugs, says Wells Fargo
Noting that data on a new Merck (MRK) HCV treatment is expected in November, Wells Fargo thinks Merck's HCV drug could be combined with Gilead's (GILD) Sovaldi to shorten the duration of treatment to four weeks. Other companies could take similar actions, and Gilead's per patient revenues would be significantly reduced if this occurs, the firm warned. However, it continues to have an upbeat outlook on Gilead heading into what it sees as a strong quarter and is still upbeat on the company's long-term HCV opportunity. It keeps an Outperform rating on Gilead.
06:43 EDTMRKGrowing market for hepatitis-C treatment prompts legal scramble, WSJ says
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use